During Women’s History Month, St. Jude Children’s Research Hospital honors its past, present and future by highlighting individual scientific research, excellence in medical care and treatment advances.
Pathologist Dorothy Williams pinpointed the first two specific genetic translocations known to cause acute lymphoblastic leukemia in the 1980s. Pat Flynn, MD, helped form the Pediatric AIDS Clinical Trial Unit in the 1990s. Jinghui Zhang, PhD, led the development of a better computer tool for finding the genetic missteps that fuel cancer in 2011.
The research of Mary Relling, PharmD, has helped change the landscape of the clinical implementation of pharmacogenomics testing. The research findings of Elaine Tuomanen, MD, have had important implications for treatment and strategies in the world of infectious diseases and the leading invasive bacterial pathogens in children. As director of the Cancer Survivorship Division, Melissa Hudson, MD, has focused on ensuring survivors of childhood cancer thrive after treatment with reduced side effects.
In 2016, pioneering women at St. Jude are making research advances in the areas of aggressive brain tumors, immunodeficiency diseases, cognitive challenges in childhood cancer survivors, blood-forming stem cells and pneumococcal infections. These scientists are carrying on the legacy set by those before them and helping set the bar for innovative progress in the research and treatment of childhood cancer and other life-threatening diseases.